Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations.
Thaler A, Anis S, Ponger P, Fay-Karmon T, Livneh V, Faust-Socher A, Greenbaum L, Reiner J, Hilel A, Shabtai H, Alcalay RN, Djaldetti R, Hassin-Baer S, Ezra A, Mirelman A, Giladi N, Gurevich T.
Thaler A, et al. Among authors: mirelman a.
Parkinsonism Relat Disord. 2024 Oct;127:107115. doi: 10.1016/j.parkreldis.2024.107115. Epub 2024 Aug 28.
Parkinsonism Relat Disord. 2024.
PMID: 39208588